Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. McCaughan · SciRah

Researcher profile · Semantic Scholar

G. McCaughan

Share profile

G. McCaughan — researcher profile on SciRah

h-index: 14
Works: 80
Citations: 672

Most-cited papers

Development of CAR T-cell lymphoma in two of ten patients effectively treated with piggyBac modified CD19 CAR T-cells.
D. Bishop, L. Clancy, R. Simms, J. Burgess +19 more
2021Blood150 citations Open access
Semantic Scholar
Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience
B. Kiely, G. McCaughan, S. Christodoulou, P. Beale +4 more
2013Supportive Care in Cancer68 citations
Semantic Scholar
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant
Wei Jiang, L. Clancy, Selmir Avdic, G. Sutrave +15 more
2022Blood Advances47 citations Open access
Semantic Scholar
Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update.
E. Favaloro, G. McCaughan, L. Pasalic
2017Pathology (Sydney)46 citations
Semantic Scholar
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic
Pietro R. Di Ciaccio, G. McCaughan, J. Trotman, P. Ho +29 more
2020Internal medicine journal (Print)41 citations Open access
Semantic Scholar
HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia.
E. Favaloro, G. McCaughan, Soma Mohammed, Kun Kan Edwin Lau +6 more
2018Pathology (Sydney)37 citations
Semantic Scholar
Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma
G. McCaughan, M. Fulham, A. Mahar, J. Soper +4 more
2016Journal of Hematology & Oncology36 citations Open access
Semantic Scholar
Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels
R. Banerjee, M. Mohan, K. Rejeski, Benjamin R. Puliafito +8 more
2025Blood Advances31 citations
Semantic Scholar
Anticoagulation at the extremes of body weight: choices and dosing
G. McCaughan, E. Favaloro, L. Pasalic, J. Curnow
2018Expert Review of Hematology29 citations
Semantic Scholar
Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis
G. McCaughan, J. Massey, I. Sutton, J. Curnow
2017BMJ Case Reports22 citations Open access
Semantic Scholar
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
F. Hoff, R. Banerjee, Adeel M. Khan, G. McCaughan +7 more
2024Blood Cancer Journal21 citations Open access
Semantic Scholar
Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review
G. McCaughan, Sara Gandolfi, J. Moore, P. Richardson
2022British Journal of Haematology21 citations Open access
Semantic Scholar
COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement
G. McCaughan, Pietro R. Di Ciaccio, M. Ananda-Rajah, N. Gilroy +31 more
2021Internal medicine journal (Print)15 citations Open access
Semantic Scholar
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians
R. Banerjee, Bo Wang, Larry D. Jr Anderson, G. McCaughan +4 more
2023Blood Cancer Journal14 citations Open access
Semantic Scholar
Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations
N. Gorrie, P. Geenty, E. Rye, V. Sivasubramaniam +5 more
2025npj Cardiovascular Health11 citations Open access
Semantic Scholar
Anticoagulation therapy in Australia
E. Favaloro, G. McCaughan, Soma Mohammed, L. Pasalic
2018Annals of Blood10 citations Open access
Semantic Scholar
Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice
Geeta Sandhu, Josephine A. Adattini, Evangeline Armstrong Gordon, Niamh O'Neill +35 more
2025EClinicalMedicine9 citations Open access
Semantic Scholar
Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients.
Kenneth J. C. Lim, C. Wellard, E. Moore, Slavisa Ninkovic +12 more
2024Clinical Lymphoma, Myeloma & Leukemia6 citations
Semantic Scholar
Retrospective Observational Study on Real-World Bortezomib Prescribing Patterns and Outcomes in Newly Diagnosed Multiple Myeloma
F. Hoff, Rahul Banerjee, Adeel M. Khan, G. McCaughan +6 more
2023Blood6 citations Open access
Semantic Scholar
Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma Australia
G. McCaughan, Hayley Beer, Christian Bryant, P. J. Ho +11 more
2025Internal medicine journal (Print)4 citations Open access
Semantic Scholar
A randomized, open-label, phase 3 study of low-dose selinexor and lenalidomide (Len) versus len maintenance post autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (NDMM): ALLG MM23, Sealand.
H. Quach, M. Lasica, D. Routledge, A. Kalff +16 more
20214 citations
Semantic Scholar
Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study
G. McCaughan, S. Tran, S. Durrant, S. Harrison +25 more
20204 citations
Semantic Scholar
Updated guidelines in the treatment of myeloma bone disease in 2025: consensus statement by the Medical and Scientific Advisory Group of Australia (MSAG) to Myeloma Australia
Angelina Yong, K. Vandyke, B. Augustson, G. McCaughan +7 more
2025Expert Review of Hematology3 citations
Semantic Scholar
Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND)
M. Rees, M. Lasica, A. Kalff, Michael Low +19 more
2025Blood3 citations
Semantic Scholar
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry
Adam Irving, D. Petrie, Anthony Harris, Laura Fanning +12 more
2024PLoS ONE3 citations Open access
Semantic Scholar
A Phase I/II Single Arm Study of Belantamab Mafodotin, Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: Planned Interim Analysis of Safety and Efficacy. Amarc 19-02 Belacard Study
M. Lasica, Andrew Spencer, N. Horvath, W. Janowski +12 more
2023Blood3 citations Open access
Semantic Scholar
Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care.
Verity L Chadwick, Michaela Kim, G. Mills, Catherine Tang +9 more
2023The Journal of the National Comprehensive Cancer Network3 citations Open access
Semantic Scholar
Real‐world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high‐risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry
Kenneth J. C. Lim, Elham Ashrafi, C. Wellard, E. Moore +15 more
2026British Journal of Haematology2 citations Open access
Semantic Scholar
An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma (MM) incorporating iberdomide, isatuximab, and dexamethasone – the IBIS study amarc 20-01.
Sueh-Li Lim, S. Mithraprabhu, J. Reynolds, W. Janowski +12 more
2025Blood2 citations
Semantic Scholar
Rates of Fertility Discussions and Counseling Before, During, and After Anticancer Treatments.
Verity Chadwick, G. Mills, Catherine Tang, A. Anazodo +6 more
2025The Journal of the National Comprehensive Cancer Network2 citations
Semantic Scholar
Variation in immunoglobulin use and impact on survival in myeloma
K. Chai, C. Wellard, Ltp Thao, N. Aoki +28 more
2024eJHaem2 citations Open access
Semantic Scholar
Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand)
H. Quach, M. Lasica, Michael Low, P. Mollee +17 more
2023Blood2 citations Open access
Semantic Scholar
Abnormal coagulation profiles in monoclonal gammopathy of undetermined significance: a case series.
G. McCaughan, S. Jarvis, J. Joseph
2021Pathology (Sydney)2 citations
Semantic Scholar
Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres
G. McCaughan, Anvita Verma, S. Ling, O. Lavee +2 more
2020Bone Marrow Transplantation2 citations
Semantic Scholar
Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia
G. McCaughan, D. Ma, J. Moore
2020Bone Marrow Transplantation2 citations
Semantic Scholar
An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly.
R. Blennerhassett, G. McCaughan, E. Tegg
2018Pathology (Sydney)2 citations Open access
Semantic Scholar
Design and Rationale of the FICAPP Study: Frailty in Cardiac Amyloidosis: Profiling the Phenotype.
E. Montgomery, N. Gorrie, G. McCaughan, Antonia S. Carroll +5 more
2026Heart, Lung and Circulation1 citations Open access
Semantic Scholar
Development and Validation of a Patient-Reported Outcome Measure to Assess the Impact of Steroids in the Treatment of Myeloma: The Steroid Symptom Questionnaire-Multiple Myeloma.
Tracy King, Louise Acret, Claudia Rutherford, Margaret-Ann Tait +5 more
2025Seminars in Oncology Nursing1 citations
Semantic Scholar
Romosozumab for Patients with Multiple Myeloma with Skeletal Events on Zoledronic Acid
G. McCaughan, B. Gration, Ryan C. Chai, J. Center +4 more
2025Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry
Kenneth J. C. Lim, C. Wellard, E. Moore, B. Gration +12 more
2024Blood1 citations
Semantic Scholar
P-380 Carfilzomib Dosing in Multiple Myeloma: An International Survey of Oncologist Practices
Sharlene Dong, N. Mehra, G. McCaughan, Bo Wang +6 more
2024Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study
Harshita Rajasekariah, G. McCaughan, C. Ma, N. Gorrie +11 more
2023Blood1 citations
Semantic Scholar
Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study
G. McCaughan, S. Tran, S. Durrant, S. Harrison +25 more
20211 citations Open access
Semantic Scholar
Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
K. Chai, C. Wellard, E. Moore, B. Augustson +20 more
2021Blood1 citations Open access
Semantic Scholar
Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma
D. Hung, D. Lenton, R. Eslick, R. Blennerhassett +4 more
2021Genes, Chromosomes and Cancer1 citations
Semantic Scholar
Australian and New Zealand Registry of Anticoagulation in the Obese: Prescribing Patterns, Drug Levels and Patient Outcomes
G. McCaughan, H. Crowther, V. Chen, S. Chunilal +6 more
20201 citations Open access
Semantic Scholar
Massive Splenomegaly, An Unexpected Diagnosis
R. Blennerhassett, G. McCaughan, Elizabeth Tegg
2019Pathology (Sydney)1 citations
Semantic Scholar
Burden, Impact, and Priorities in Amyloidosis: Findings from the International Amyloid Patient Experiences Survey (AMPES).
N. Gorrie, Katie Hewitt, G. McCaughan, N. Bart +3 more
2026Journal of Cardiac Failure0 citations
Semantic Scholar
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study
Samantha Kurniawan, A. Hwang, N. W. Doo, Tracy King +14 more
2026Asia-Pacific Journal of Clinical Oncology0 citations Open access
Semantic Scholar
NSP-06 Consensus Recommendations for Delivering Bispecific Antibody Therapy (BsAB) in Multiple Myeloma (MM): An Evidence-Based Framework
Tracy King, Ty Simpson, D. Klarica, Laura Jones +7 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Quach×15
Invite
H. Quach — researcher profile on SciRah
N. Hamad×11
Invite
N. Hamad — researcher profile on SciRah
P. Mollee×7
Invite
P. Mollee — researcher profile on SciRah
C. Wellard×6
Invite
C. Wellard — researcher profile on SciRah

×6

Invite

E. Moore — researcher profile on SciRah

Invite

N. Horvath — researcher profile on SciRah

B. Augustson×6

Invite

B. Augustson — researcher profile on SciRah

Invite

G. Kaur — researcher profile on SciRah

Invite

J. Moore — researcher profile on SciRah

D. Routledge×5

Invite

D. Routledge — researcher profile on SciRah

Invite

A. Kalff — researcher profile on SciRah

Invite

M. Sidiqi — researcher profile on SciRah